Description: Medical More provides medical technology news and analysis for industry professionals. We cover medical devices, diagnostics, digital health, FDA regulation and compliance, imaging, and more.
Fresenius plans to start a broad market launch next year and push to establish hemodiafiltration as the new standard of care. Read more ➔
The clearance positions Insulet to sell the integrated Type 1 diabetes product in Europe beginning in the first half of the year.
The heart valve specialist has the chance to shape a new tricuspid market with the first-of-its-kind device, like it did 20 years ago in TAVR, CEO Bernard Zovighian said.